Search Results - "Lang, IM"

Selexipag for the Treatment of Pulmonary Arterial Hypertension by Sitbon, Olivier, Channick, Richard, Chin, Kelly M, Frey, Aline, Gaine, Sean, Galiè, Nazzareno, Ghofrani, Hossein-Ardeschir, Hoeper, Marius M, Lang, Irene M, Preiss, Ralph, Rubin, Lewis J, Di Scala, Lilla, Tapson, Victor, Adzerikho, Igor, Liu, Jinming, Moiseeva, Olga, Zeng, Xiaofeng, Simonneau, Gérald, McLaughlin, Vallerie V

“…Among over 1100 patients with pulmonary arterial hypertension who received selexipag, an oral selective IP prostacyclin-receptor agonist, or placebo, the risk…”
Get full text

Chronic Thromboembolic Pulmonary Hypertension — Not So Rare after All by Lang, Irene M

“…Chronic thromboembolic pulmonary hypertension (CTPH) is believed to result from single or recurrent pulmonary thromboemboli arising from sites of venous…”
Get full text

Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel by Siller-Matula, Jolanta M., MD, Spiel, Alexander O., MD, Lang, Irene M., MD, Kreiner, Gerhard, MD, Christ, Guenter, MD, Jilma, Bernd, MD

“…Background Clopidogrel is activated by CYP2C19, which also metabolizes proton pump inhibitors (PPI). As proton pump inhibitors are metabolized to varying…”
Get full text

Interaction of factor VII activating protease (FSAP) with neutrophil extracellular traps (NETs) by Grasso, Simona, Neumann, Ariane, Lang, Irene M., Etscheid, Michael, von Köckritz-Blickwede, Maren, Kanse, Sandip M.

“…The circulating zymogen form of Factor VII activating protease (FSAP) can be activated by histones and nucleosomes in vivo. These cell-death-associated nuclear…”
Get full text

Cellular and molecular pathobiology of pulmonary arterial hypertension by Humbert, Marc, Morrell, Nicholas W, Archer, Stephen L, Stenmark, Kurt R, MacLean, Margaret R, Lang, Irene M, Christman, Brian W, Weir, E.Kenneth, Eickelberg, Oliver, Voelkel, Norbert F, Rabinovitch, Marlene

“…Pulmonary arterial hypertension (PAH) has a multifactorial pathobiology. Vasoconstriction, remodeling of the pulmonary vessel wall, and thrombosis contribute…”
Get full text

Abciximab as a bridging strategy to overcome morphine–prasugrel interaction in STEMI patients by Siller‐Matula, Jolanta M., Specht, Simon, Kubica, Jacek, Alexopoulos, Dimitrios, De Caterina, Raffaele, Hobl, Eva‐Luise, Jilma, Bernd, Christ, Günter, Lang, Irene M.

“…Objective The present study investigated whether the glycoprotein (GP)IIb/IIIa receptor blocker abciximab might be a successful bridging strategy to achieve…”
Get full text

Characterization and mechanisms of the supragastric belch in the cat by Lang, Ivan M, Medda, Bidyut K, Shaker, Reza

“…A response in which a belch occurs without gastric involvement, i.e., the supragastric belch (SGB), has been characterized in humans. The aims of this study…”
Get more information

Indications, outcomes and complications after ECMO implantation in the cath lab - a single-center retrospective study by Kralicek, S, Meier, CS, Distelmaier, K, Niessner, A, Heinz, G, Lang, IM, Hengstenberg, C, Krychtiuk, KA, Speidl, WS

“…Abstract Funding Acknowledgements Type of funding sources: None. Background Despite the increase of extracorporeal membrane oxygenation (ECMO) employment…”
Get full text

P728CD4+CD28 null T cells are enriched at the culprit lesion site in STE-ACS and promote NET production by Scherz, T, Mangold, A, Hofbauer, T, Adlbrecht, C, Lang, IM

Get full text

Dyspnea after pulmonary embolism: a nation-wide population-based case–control study by Nilsson, Lars T., Andersson, Therese, Larsen, Flemming, Lang, Irene M., Liv, Per, Söderberg, Stefan

“…Dyspnea is common after a pulmonary embolism. Often, but not always, the dyspnea can be explained by pre-existing comorbidities, and only rarely by chronic…”
Get full text

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) by Konstantinides, Stavros V, Meyer, Guy, Becattini, Cecilia, Bueno, Héctor, Geersing, Geert-Jan, Harjola, Veli-Pekka, Huisman, Menno V, Humbert, Marc, Jennings, Catriona Sian, Jiménez, David, Kucher, Nils, Lang, Irene Marthe, Lankeit, Mareike, Lorusso, Roberto, Mazzolai, Lucia, Meneveau, Nicolas, Áinle, Fionnuala Ní, Prandoni, Paolo, Pruszczyk, Piotr, Righini, Marc, Torbicki, Adam, Van Belle, Eric, Zamorano, José Luis

Get full text

Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension by Bonderman, Diana, Nowotny, Regina, Skoro-Sajer, Nika, Jakowitsch, Johannes, Adlbrecht, Christopher, Klepetko, Walter, Lang, Irene M

“…Bosentan, an oral endothelin (ET)-A/ET-B receptor antagonist, is effective in the treatment of pulmonary arterial hypertension. To investigate the safety and…”
Get more information

P726Coronary NET burden and DNase activity in ST-elevation acute coronary syndrome are predictors of infarct size by Mangold, A, Scherz, T, Alias, S, Hofbauer, T, Jakowitsch, J, Bangert, C, Pfaffenberger, S, Winter, MP, Preissner, KT, Lang, IM

Get full text

High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension by Bonderman, Diana, Turecek, Peter L, Jakowitsch, Johannes, Weltermann, Ansgar, Adlbrecht, Christopher, Schneider, Barbara, Kneussl, Meinhard, Rubin, Lewis J, Kyrle, Paul A, Klepetko, Walter, Maurer, Gerald, Lang, Irene M

“…Chronic thromboembolic pulmonary hypertension (CTEPH) is an enigmatic disorder lacking signs, symptoms and classical risk factors for venous thromboembolism…”
Get more information

Mechanisms underlying aortic dilatation in congenital aortic valve malformation by BONDERMAN, D, GHAREHBAGHI-SCHNELL, E, WOLLENEK, G, MAURER, G, BAUMGARTNER, H, LANG, I. M

“…The high incidence of aortic disease in subjects with congenital aortic valve malformations suggests a causative relationship between these 2 conditions. The…”
Get full text

Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque by Bonderman, Diana, Teml, Alexander, Jakowitsch, Johannes, Adlbrecht, Christopher, Gyöngyösi, Mariann, Sperker, Wolfgang, Lass, Harald, Mosgoeller, Wilhelm, Glogar, Dietmar H., Probst, Peter, Maurer, Gerald, Nemerson, Yale, Lang, Irene M.

“…Defined angiographically, no-reflow (NR) manifests as an acute reduction in coronary flow in the absence of epicardial vessel obstruction. One candidate…”
Get full text

Mechanisms of reflexes induced by esophageal distension by Lang, I M, Medda, B K, Shaker, R

“…We investigated the mechanisms of esophageal distension-induced reflexes in decerebrate cats. Slow air esophageal distension activated esophago-upper…”
Get more information

A Clinical Comparison of Slow- and Rapid-Escalation Treprostinil Dosing Regimens in Patients with Pulmonary Hypertension by Skoro-Sajer, Nika, Lang, Irene M., Harja, Evis, Kneussl, Meinhard P., Sing, Wendy Gin, Gibbs, Simon J. R.

“…Background and objective: Subcutaneous treprostinil is an effective treatment for pulmonary arterial hypertension (PAH). A previous pivotal study indicated…”
Get full text

Relative contribution of various airway protective mechanisms to prevention of aspiration during swallowing by Medda, Bidyut K, Kern, Mark, Ren, Junlong, Xie, Pengyan, Ulualp, Seckin O, Lang, Ivan M, Shaker, Reza

“…Deglutitive airway protective mechanisms include glottal closure, epiglottal descent, and anterosuperior displacement of the larynx. Aspiration of swallowed…”
Get more information

Mechanisms of airway protection during retching, vomiting, and swallowing by Lang, Ivan M, Dana, Nicole, Medda, Bidyut K, Shaker, Reza

“…We investigated the mechanisms of airway protection and bolus transport during retching and vomiting by recording responses of the pharyngeal, laryngeal, and…”
Get more information